Mankind Pharma Limited has notified the BSE and NSE that it has received an order from the Additional Commissioner, CGST, Gurugram, dated November 14, 2025, under Section 73 of the Central Goods and Services Tax Act, 2017.
According to the company’s stock exchange filing, the order pertains to FY 2021–22 and imposes a penalty of ₹83,00,790, arising from the alleged disallowance of Input Tax Credit (ITC) under Section 16(4) of the CGST Act.
Company Calls Order Unjustified
Mankind Pharma stated that, based on its evaluation of the facts and applicable law, the order is “arbitrary and unjustified.”
The company confirmed its intention to file an appeal with the relevant appellate authority.
No Financial or Operational Impact
In its disclosure, Mankind Pharma clarified that the order has no material impact on the company’s financials, day-to-day operations, or ongoing activities.